Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes

Expression of miR-122/155 differ in each genotypes, miR-122ser could be independent factor affecting the therapy efficacy, which had higher diagnostic value in predicting HCV outcome.